LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: A phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
Many patients report feeling improvements in pain reduction and mobility fairly quickly, with healing accelerating as the treatment progresses
Andrews N, Miller E, Grant A, Stowe J, Osborne V, Taylor B: Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association
Branched chain amino acids and carbohydrate restriction exacerbate ketogenesis and hepatic mitochondrial oxidative dysfunction during NAFLD
Low levels of B-12 cause your folate levels to drop